Poster in Medical Technology
Navigation Links
Poster in Medical Technology
Phase 2 Results of Perifosine in the Treatment of Patients with Relapsed/Refractory Waldenstrom's Macroglobulinemia to be presented Tomorrow, Tuesday, June 3rd at 12:00pm in Room E450a
NEW YORK, June 2 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals,
Inc. (Nasdaq: KERX ) toda...
Preliminary Analysis of rEEG(R) Guided Medication Study Demonstrates an Improvement in Depression and Eating Disorder Symptoms COSTA MESA, Calif., May 22 /PRNewswire-FirstCall/ -- CNS Response, Inc. (OTC Bulletin Board: CNSO) reported today the results of a study presented at the Ameri...
DALLAS, Oct. 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that two posters describing significant preclinical studies performed by Access collaborators at two prominent institutes in France, were presented last week at the joint symposium...
VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Apr 13, 2007 - Gentium, S.p.A. (NASDAQ:GENT) (the "Company") today reported that its lead investigational product, Defibrotide, will be the subject of two poster presentations at the American Association for Cancer Research's (AACR) Annual Meeting being...
DALLAS, April 16, 2007 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. announced today that results of studies of the mechanism of ProLindac's anticancer activity will be presented today at the American Association for Cancer Research (AACR) 2007 annual meeting in Los Angeles at the Los Ang...
WALTHAM, Mass.--(BUSINESS WIRE)--May 7, 2007 - OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a clinical-stage biotechnology company developing novel therapeutics to treat cancer and eye diseases, announced today that the results of its Phase II combretastatin A4 phosphate (CA4P) clinical trial in myopi...
REGENSBURG, Germany, May 10th, 2007 - Antisense Pharma, a German biopharmaceutical company specialized in targeted therapies for malignant tumors, today announced, that data from the Phase IIb-study with AP 12009 in high-grade glioma will be presented at the 43rd Annual Meeting of the American Soc...
EXETER, N.H.--(BUSINESS WIRE)--May 24, 2007 - Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that a late breaking abstract sponsored by the Company has been accepted for a poster presentation at the American Diabetes Association 67th Scientific Sessio...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 6, 2007 - Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that two abstracts exploring Phase 2 Puricase(R) (PEG-uricase) data and quality of life in treatment-failure gout patients will be presented at the European League Against Rheumatism (E...
NEW YORK, June 22, 2007 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced that abstracts related to Sulonex(TM) (sulodexide oral gelcap) have been selected for publication or presentation during the poster sessions scheduled to take place at the upcoming American Diabetes As...
- Article Discussing Pharmacokinetics and Dose Proportionality of Company's Once-Daily Tramadol to be Published in Biopharmaceutics Journal - LAVAL, QC, June 29, 2007 /PRNewswire-FirstCall/ - Labopharm Inc. today announced that it will present a poster discussing the dose titration of its once-dai...
SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced today that it will present clinical and preclinical data on its oral Factor Xa inhibitor and on its intravenous and oral ADP receptor antagonist at the XXI Congress of the International Society of Thrombosis...
...vidence of disease progression, and six patients were alive at time of data presentation. Median progression free survival was 3.3 months. This poster is available at www.celltherapeutics.com/investor_updates About (product) OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly k...
...ment and Prevention (IAS 2009), July 19 -22, 2009, poster LBPEB07. (2) Data on File (3) ...ment and Prevention (IAS 2009), July 19 -22, 2009, poster LBPEB07. (4) Soriano, V et al., Prospecti...ment and Prevention (IAS 2009), July 19 -22, 2009, poster LBPEB07. ...
...Seizures: Pooled Analysis of Three Double-Blind Phase III Clinical Studies. poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 200...ng-Term Treatment with Eslicarbazepine Acetate: BIA-2093-301 Study.QOL 301. poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 200...
...relapsed/refractory indolent NHL, nearly all of whom had received aggressive first-line therapy with CHOP-R. The Pan Pacific Lymphoma Conference poster is available at http://www.celltherapeutics.com/investor_updates . About the PIX 301 EXTEND Trial The PIX 301 EXTEND trial was a phase III...
...lthcare professionals through conference coverage and other educational programs. The ASCO summaries are "quick read" reviews of key oral sessions and poster presentations, which are handpicked by leading experts in oncology and hematology for the Clinical Care Options website. About Cell Therapeutics...
...o 7 in Berlin, Germany. Blinatumomab is a novel therapeutic antibody that activates a patient's T cells to seek out and destroy cancer cells. The poster presentation gave an update of an ongoing phase 1 trial of blinatumomab in relapsed NHL patients including a follow-up on response duration as well as...
...eports with the SEC or posts certain other information to the website. poster #466-P; Session PO01, June 6, 11:30 A.M. - 1:30 P.M. poster #479-P; Session PO02, June 7, 12:00 P.M. - 2:00 P.M. CONTACT: Alanna...
...Line Results - NEW ORLEANS, June 6, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today a late-breaking poster presentation of positive results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal t...
... ligation, and specimen retrieval. The study, which is being presented as a poster at DDW, involved porcine models and was conducted by investigators from Sah...l the promise of this approach to minimally invasive surgery." Another poster presentation entitled "Hybrid Transgastric NOTES Cholecystectomy in a Porci...
...erapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that at the poster and discussion session of the Lymphoma and Plasma Cell Disorders Section at...infarction, cyanosis, pericardial effusion, and tachycardia. The ASCO poster is available at http://www.celltherapeutics.com/investor_updates . ...
...m at Karmanos. Ammar Sukari, M.D., assistant professor of medicine and fellow member of the Head and Neck Cancer Multidisciplinary Team, conducted the poster presentation. "What the study found is that low-dose, long-term adjuvant therapy is feasible," said Dr. Yoo. "We are pleased with the results. Th...
... Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association'... CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in cat...nt, Clinical Development, will be available at the poster to discuss and address questions during two period...
...ne during the "Lymphoma and Plasma Cell Disorders" poster session. "In spite of advances in the treatme...ents during the Lymphoma and Plasma Cell Disorders poster session. Interim results from a Phase 2 cli...at Washington University School of Medicine in a poster titled "PX-171-004, a multicenter Phase II study o...
...econd- or third-line metastatic colon cancer," was presented yesterday in a poster during the Gastrointestinal Cancer -- Colorectal session at the 45th Annual...-line through the ASCO website: http://www.asco.org/ . A copy of the poster may be obtained by contacting the Company. KRX-0401 (perifosine) is in...
... Abstract 1273: Time to Onset of Linaclotide Effect on the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2b Study , a poster presentation by Jeffrey Johnston, M.D., F.A.C.P., F.A.C.G. on Tuesday, June 2 from 8:00 a.m. to 5:00 p.m. CT; McCormick Place, South Hall ...
...cond- or third-line metastatic colon cancer," is being presented today in a poster during the Gastrointestinal Cancer - Colorectal session at the 45th Annual ...ed on-line through the ASCO website: http://www.asco.org/ . A copy of the poster may be obtained by contacting the Company. About Colon Cancer Acc...
...a VEGF receptor," was presented earlier today in a poster session at the 45th Annual Meeting of the American...he Cleveland Clinic Taussig Cancer Institute, in a poster discussion during the Genitourinary Cancer session...ebsite: http://www.asco.org/ . A copy of the poster presented earlier today may be obtained by contact...
...cer test in a large number of male patients for whom the test was used to guide treatment with chemotherapy. The results, which will be presented in a poster presentation on Monday, June 1 (1:00 - 5:00 p.m. ET) at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, demonstrated that ...
...ts with advanced solid tumors and lymphomas" poster Presentation: Friday, May 29, 2 pm - 6 pm EDT, Level 3, W315A, Board 13 poster Discussion: Friday, May 29, 5 pm - 6 pm EDT, Level 4, Valencia ...
...linical Oncology's 2009 Annual Meeting in Orlando, Fla., during the General poster Session on Monday, June 1, from 8:00 a.m. to noon Eastern Time (abstract #4026) in W240A, Level 2, with a discussion of the poster scheduled from 11:30 a.m. to 11:45 a.m. in West Hall E1, Level 2. Pha...
Preliminary Analysis of rEEG(R) Guided Medication Study Demonstrates an Improvement in Depression and Eating Disorder Symptoms COSTA MESA, Calif., May 22 /PRNewswire-FirstCall/ -- CNS Response, Inc. (OTC Bulletin Board: CNSO) reported today the results of a study presented at the Ameri...
DALLAS, Oct. 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that two posters describing significant preclinical studies performed by Access collaborators at two prominent institutes in France, were presented last week at the joint symposium...
Metabasis Therapeutics to Present Poster at American Association for Cancer Research
SAN DIEGO, March 22, 2007 /PRNewswire-FirstCall/ -- Metabasis Therapeutics, Inc. announced today that a poster entitled, "A Phase I/II Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MB07133 in Subjects with Unresectable Hepatocellular Carcinoma (...VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Apr 13, 2007 - Gentium, S.p.A. (NASDAQ:GENT) (the "Company") today reported that its lead investigational product, Defibrotide, will be the subject of two poster presentations at the American Association for Cancer Research's (AACR) Annual Meeting being...
DALLAS, April 16, 2007 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. announced today that results of studies of the mechanism of ProLindac's anticancer activity will be presented today at the American Association for Cancer Research (AACR) 2007 annual meeting in Los Angeles at the Los Ang...
Gentium's Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Apr 23, 2007 - Gentium S.p.A. (NASDAQ: GENT) (the "Company") today reported that its lead product, Defibrotide, will be the subject of a poster presentation at the World Congress of Nephrology 2007 being held in Rio de Janeiro, Brazil from April 21-25, ...WALTHAM, Mass.--(BUSINESS WIRE)--May 7, 2007 - OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a clinical-stage biotechnology company developing novel therapeutics to treat cancer and eye diseases, announced today that the results of its Phase II combretastatin A4 phosphate (CA4P) clinical trial in myopi...
REGENSBURG, Germany, May 10th, 2007 - Antisense Pharma, a German biopharmaceutical company specialized in targeted therapies for malignant tumors, today announced, that data from the Phase IIb-study with AP 12009 in high-grade glioma will be presented at the 43rd Annual Meeting of the American Soc...
EXETER, N.H.--(BUSINESS WIRE)--May 24, 2007 - Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that a late breaking abstract sponsored by the Company has been accepted for a poster presentation at the American Diabetes Association 67th Scientific Sessio...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 6, 2007 - Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that two abstracts exploring Phase 2 Puricase(R) (PEG-uricase) data and quality of life in treatment-failure gout patients will be presented at the European League Against Rheumatism (E...
NEW YORK, June 22, 2007 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. today announced that abstracts related to Sulonex(TM) (sulodexide oral gelcap) have been selected for publication or presentation during the poster sessions scheduled to take place at the upcoming American Diabetes As...
- Article Discussing Pharmacokinetics and Dose Proportionality of Company's Once-Daily Tramadol to be Published in Biopharmaceutics Journal - LAVAL, QC, June 29, 2007 /PRNewswire-FirstCall/ - Labopharm Inc. today announced that it will present a poster discussing the dose titration of its once-dai...
SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced today that it will present clinical and preclinical data on its oral Factor Xa inhibitor and on its intravenous and oral ADP receptor antagonist at the XXI Congress of the International Society of Thrombosis...
...vidence of disease progression, and six patients were alive at time of data presentation. Median progression free survival was 3.3 months. This poster is available at www.celltherapeutics.com/investor_updates About (product) OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly k...
...ment and Prevention (IAS 2009), July 19 -22, 2009, poster LBPEB07. (2) Data on File (3) ...ment and Prevention (IAS 2009), July 19 -22, 2009, poster LBPEB07. (4) Soriano, V et al., Prospecti...ment and Prevention (IAS 2009), July 19 -22, 2009, poster LBPEB07. ...
...Seizures: Pooled Analysis of Three Double-Blind Phase III Clinical Studies. poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 200...ng-Term Treatment with Eslicarbazepine Acetate: BIA-2093-301 Study.QOL 301. poster presented at the American Epilepsy Society (AES) Congress, 5-9 December 200...
...relapsed/refractory indolent NHL, nearly all of whom had received aggressive first-line therapy with CHOP-R. The Pan Pacific Lymphoma Conference poster is available at http://www.celltherapeutics.com/investor_updates . About the PIX 301 EXTEND Trial The PIX 301 EXTEND trial was a phase III...
...lthcare professionals through conference coverage and other educational programs. The ASCO summaries are "quick read" reviews of key oral sessions and poster presentations, which are handpicked by leading experts in oncology and hematology for the Clinical Care Options website. About Cell Therapeutics...
...o 7 in Berlin, Germany. Blinatumomab is a novel therapeutic antibody that activates a patient's T cells to seek out and destroy cancer cells. The poster presentation gave an update of an ongoing phase 1 trial of blinatumomab in relapsed NHL patients including a follow-up on response duration as well as...
...eports with the SEC or posts certain other information to the website. poster #466-P; Session PO01, June 6, 11:30 A.M. - 1:30 P.M. poster #479-P; Session PO02, June 7, 12:00 P.M. - 2:00 P.M. CONTACT: Alanna...
New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar
...aking basal insulin, Lantus(R) (insulin glargine [rDNA origin] injection), with or without oral antidiabetic drugs (OADs).The study was presented as a poster during the 69th Annual Scientific Sessions of the American Diabetes Association (ADA). The study was a multicenter, randomized, open-label, par......Line Results - NEW ORLEANS, June 6, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today a late-breaking poster presentation of positive results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal t...
... ligation, and specimen retrieval. The study, which is being presented as a poster at DDW, involved porcine models and was conducted by investigators from Sah...l the promise of this approach to minimally invasive surgery." Another poster presentation entitled "Hybrid Transgastric NOTES Cholecystectomy in a Porci...
CuraGen Updates CR011-vcMMAE Data at ASCO
...ant new target in breast cancer." Also at ASCO, data from a Phase II trial of CR011-vcMMAE in patients with advanced melanoma were presented at a poster discussion session. Thirty-six patients were enrolled into this Phase II open-label, multi-center trial that evaluated the efficacy and safety of CR01......erapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that at the poster and discussion session of the Lymphoma and Plasma Cell Disorders Section at...infarction, cyanosis, pericardial effusion, and tachycardia. The ASCO poster is available at http://www.celltherapeutics.com/investor_updates . ...
...m at Karmanos. Ammar Sukari, M.D., assistant professor of medicine and fellow member of the Head and Neck Cancer Multidisciplinary Team, conducted the poster presentation. "What the study found is that low-dose, long-term adjuvant therapy is feasible," said Dr. Yoo. "We are pleased with the results. Th...
... Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association'... CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in cat...nt, Clinical Development, will be available at the poster to discuss and address questions during two period...
...ne during the "Lymphoma and Plasma Cell Disorders" poster session. "In spite of advances in the treatme...ents during the Lymphoma and Plasma Cell Disorders poster session. Interim results from a Phase 2 cli...at Washington University School of Medicine in a poster titled "PX-171-004, a multicenter Phase II study o...
...econd- or third-line metastatic colon cancer," was presented yesterday in a poster during the Gastrointestinal Cancer -- Colorectal session at the 45th Annual...-line through the ASCO website: http://www.asco.org/ . A copy of the poster may be obtained by contacting the Company. KRX-0401 (perifosine) is in...
Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
... week in Orlando, Florida. Data were presented in both oral discussion and poster sessions. (Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDL...of ENMD-2076, partnering discussions continue." To view a copy of the poster and slide presentations, visit Scientific Presentations under the Therapeut...TNFerade(TM) Phase III Data Presented at ASCO
...: http://www.newscom.com/cgi-bin/prnh/20081205/DC50112LOGO ) The poster , entitled "Multi-Center Randomized Controlled Phase III Clinical Tria...y the survival trend being observed at this point in the trial." This poster can be accessed online by visiting www.genvec.com and clicking on "Inve...... Abstract 1273: Time to Onset of Linaclotide Effect on the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2b Study , a poster presentation by Jeffrey Johnston, M.D., F.A.C.P., F.A.C.G. on Tuesday, June 2 from 8:00 a.m. to 5:00 p.m. CT; McCormick Place, South Hall ...
...cond- or third-line metastatic colon cancer," is being presented today in a poster during the Gastrointestinal Cancer - Colorectal session at the 45th Annual ...ed on-line through the ASCO website: http://www.asco.org/ . A copy of the poster may be obtained by contacting the Company. About Colon Cancer Acc...
...a VEGF receptor," was presented earlier today in a poster session at the 45th Annual Meeting of the American...he Cleveland Clinic Taussig Cancer Institute, in a poster discussion during the Genitourinary Cancer session...ebsite: http://www.asco.org/ . A copy of the poster presented earlier today may be obtained by contact...
...cer test in a large number of male patients for whom the test was used to guide treatment with chemotherapy. The results, which will be presented in a poster presentation on Monday, June 1 (1:00 - 5:00 p.m. ET) at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, demonstrated that ...
...ts with advanced solid tumors and lymphomas" poster Presentation: Friday, May 29, 2 pm - 6 pm EDT, Level 3, W315A, Board 13 poster Discussion: Friday, May 29, 5 pm - 6 pm EDT, Level 4, Valencia ...
...linical Oncology's 2009 Annual Meeting in Orlando, Fla., during the General poster Session on Monday, June 1, from 8:00 a.m. to noon Eastern Time (abstract #4026) in W240A, Level 2, with a discussion of the poster scheduled from 11:30 a.m. to 11:45 a.m. in West Hall E1, Level 2. Pha...
CuraGen to Present CR011-vcMMAE Data at ASCO
...ents with advanced melanoma. Sunday, May 31, 2009, poster presentation from 8:00 AM - 12:00 PM with a discus...ents with advanced melanoma. Monday, June 1, 2009, poster presentation from 8:00 AM - 12:00 PM. #1067 ...or metastatic breast cancer. Monday, June 1, 2009, poster presentation from 1:00 PM - 5:00 PM. Abstract...TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
...M - 6:00 PM Session Title: Developmental Therapeutics Session Type: poster Discussion Abstract Number: 3518 TRC102 Abstract Title: A Phas... - 12:00 PM Session Title: Developmental Therapeutics Session Type: poster Presentation Abstract Number: 2552 About TRACON TRACON Pharma...Other TagsacquisitionacquisitionIPOIPOIPOIPOIPOIPOIPOsecureshareharehareexecexecinfrastructuremisleadOther Contentstearstearstearstearsmeniscusmeniscusmenorrhagiaperiodsperiodsperiodsperiodsperiodsperiodsperiodsperiodsperiodsmenstrualmenstrualmenstrualmenstrualmenstrualmentalmentalmentalmentalmentalmentalmentalmentalmesotheliomamesotheliomamesotheliomametabolicmetabolicmetabolicmetabolicmetabolicmetabolicmetabolicmetabolicmetabolic
featuredworkplacesMutualacquisitionIPOdiscontinuePhenomenellesecureshareTortoiseexecflatteninginfrastructuremislead
(Date:12/3/2009)... PHILADELPHIA Now in its 32nd year, the CTRC-AACR ... best in breast cancer science and world leaders from ... cancer. , This year, more than 8,500 scientists ... Gonzales Convention Center in San Antonio from Dec. 9-13, ...
(Date:12/3/2009)... be included in the design of the upcoming forest deal ... to a scientist at the University of Leeds. , ... that at least 50% of the carbon credit payments to ... Deforestation and Degredation), should be made to forest dwellers directly, ...
(Date:12/2/2009)... PHILADELPHIA Children exposed to secondhand cigarette smoke have an ... they never smoked. , Results of this study are ... journal of the American Association for Cancer Research, as part ... , This year alone, more than 219,000 Americans will be ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cantel Medical Corp to Present at the Sidoti Emerging Growth Research Institutional Investor Forum 6016 1Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 1Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 3Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 6006 1Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 6006 2Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 6006 3(Date:12/5/2009)... Technology Center helps companies develop and test their cleaning processes. The ... variety of industries and solve problems for customers relating to cleaning ... ... 5, 2009 -- Midbrook, Inc , a Jackson, MI-based company, ...
(Date:12/5/2009)... is a collaborative effort by the National Association ... North America (MANA), Citizens for Midwifery (CfM), International ... of Midwives (NARM), and the Midwifery Education Accreditation ... efforts of The MAMA Campaign to secure federal ...
(Date:12/4/2009)... ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: ... has set the regular 2010 Annual Meeting of Stockholders for ... 2009. The meeting will be held at the Crowne Plaza ... 4:30 p.m. PT. ,, The meeting will be webcast by ...
(Date:12/4/2009)... LLP employees came together in more than 90 offices nationwide ... the audit, tax and advisory firm,s support for literacy with ... firm,s long history of volunteerism. Instead of holiday parties, our ... holidays for some children," said Tim Flynn, Chairman of KPMG. ...
(Date:12/4/2009)... Holdings, Ltd (NYSE: AWH ) today announced ... Sennott, Executive Vice,President and Chief Corporate Strategy Officer, will ... Conference being held at the Goldman,Sachs Conference Center in ... About Allied World Assurance Company ...
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto[0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |